Search for: "Blood Systems Inc" Results 321 - 340 of 794
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Sep 2011, 7:02 am by Cal Warriner
At the time of the recall, the reported failure rate for these two systems was 13%. [read post]
19 Sep 2011, 1:44 pm by Ronald V. Miller, Jr.
Infected babies who survive are likely to be born prematurely, while others may be born severely ill or get sick soon after birth, with problems that can include blood infection, difficulty breathing, fever, skin sores, lesions on multiple organs, and central nervous system infections such as meningitis. [read post]
19 Sep 2011, 7:02 am by Cal Warriner
At the time of the recall, the reported failure rate for these two systems was 13%. [read post]
22 May 2007, 4:54 am
"Our system of jurisprudence has evolved to where it protects lawyers who seek to make a difference," the motion says. [read post]
10 Aug 2012, 7:27 am by Ed Wallis
Bard Inc., manufacturer of a transvaginal mesh product that has been linked to high failure rates, now has a judgment against them in favor of Christine Scott, as well as her husband, in the amount of $5.5 million after C.R. [read post]
8 May 2017, 8:50 am by Rebecca Tushnet
Scram of California, Inc., No. 17-cv-01474, 2017 WL 1628401 (C.D. [read post]
21 Nov 2008, 4:13 pm
Earhart was a corporate officer and the President of the Optical Division of Allergan, Inc. [read post]
27 Jul 2012, 1:21 am by FDABlog HPM
Circuit (appeal no. 11-1268),  relates to two medical devices for which Cytori Therapeutics, Inc., of San Diego, California, sought clearance. [read post]
26 Jul 2010, 10:41 pm by Tom
The latter two test will be useful in selecting the maximum effective dosage of Warfarin (blood thinner) specific to the patient’s DNA to prevent the formation of blood clots in the legs that can lead to pulmonary emboli (blood clots in the lungs), which is a life-threatening condition. [read post]
29 Mar 2012, 3:35 am by war
Prometheus Labs., Inc. [read post]
12 Sep 2008, 10:24 am
When a potential signal of a possible risk is identified from AERS data, it is entered as a possible safety issue into CDER's Document Archiving, Reporting, and Regulatory Tracking System (DARRTS) or into CBER's Therapeutics and Blood Safety Branch Safety Signal Tracking (SST) system. [read post]